Publications
Partners
- The US CDC warned that people with specific allergic reactions should not get the Covid-19 vaccination.
- Five people had allergic reaction to the vaccine in the US.
- In the UK, authorities advised that anyone with a history of anaphylaxis should not get the vaccine.
The US Centres for Disease Control and Prevention (CDC) on Saturday said it was monitoring reports of allergic reactions to the Covid-19 vaccination and made recommendations on how people with histories of allergies should proceed.
LIVE | All the latest coronavirus and lockdown updates
Anyone who had a severe reaction to a Covid-19 vaccine should not get the second dose, the agency said, defining severe as needing the medication epinephrine or treatment in a hospital.
People who have had a severe allergic reaction to any ingredient in a Covid-19 vaccine should avoid the vaccine formulation containing the ingredient, CDC said.
Two vaccines have been approved in the United States under emergency use authorisations.
Individuals with histories of severe allergic reaction to vaccines should consult their doctors about the Covid-19 shot.
The CDC said people with severe allergies to food, pets, latex or environmental conditions as well as people with allergies to oral medication or a family history of severe allergic reactions could still get vaccinated.
The US Food and Drug Administration is investigating around five allergic reactions that happened after people were administered Pfizer Inc and BioNTech SE's Covid-19 vaccine in the United States this week.
On Friday, the FDA said that the Moderna Inc vaccine, which received emergency use authorisation, should not be given to individuals with a known history of a severe allergic reaction to any components of the shot.
Britain's medical regulator has said that anyone with a history of anaphylaxis, or severe allergic reactions to a medicine or food, should not be given the Pfizer-BioNTech Covid-19 vaccine.
Do you want to know more about this topic? Sign up for one of News24's 33 newsletters to receive the information you want in your inbox. Special newsletters are available to subscribers.
